127 related articles for article (PubMed ID: 37592848)
21. Bilateral synchronous high-grade serous carcinoma and clear cell carcinoma in right and left ovaries with immunohistochemical confirmation: an exceptional finding.
Preeti A; Arunachalam KA; Pradeep Y; Mati GM
Indian J Pathol Microbiol; 2014; 57(4):623-5. PubMed ID: 25308023
[TBL] [Abstract][Full Text] [Related]
22. Imaging in gynecological disease (17): ultrasound features of malignant ovarian yolk sac tumors (endodermal sinus tumors).
Anfelter P; Testa A; Chiappa V; Froyman W; Fruscio R; Guerriero S; Alcazar JL; Mascillini F; Pascual MA; Sibal M; Savelli L; Zannoni GF; Timmerman D; Epstein E
Ultrasound Obstet Gynecol; 2020 Aug; 56(2):276-284. PubMed ID: 32119168
[TBL] [Abstract][Full Text] [Related]
23. Radiological findings in serous surface papillary carcinoma of the ovary. Case reports.
Kim SH; Cho JY; Park IA; Kang SB; Lee HP; Han MC
Acta Radiol; 1997 Sep; 38(5):847-9. PubMed ID: 9332242
[TBL] [Abstract][Full Text] [Related]
24. Assessment of ovarian tumors using transvaginal color Doppler ultrasonography.
Daskalakis G; Kalmantis K; Skartados N; Thomakos N; Hatziioannou L; Antsaklis A
Eur J Gynaecol Oncol; 2004; 25(5):594-6. PubMed ID: 15493173
[TBL] [Abstract][Full Text] [Related]
25. Ovarian Combined Low-grade Serous and Mesonephric-like Adenocarcinoma: Further Evidence for A Mullerian Origin of Mesonephric-like Adenocarcinoma.
McCluggage WG; Vosmikova H; Laco J
Int J Gynecol Pathol; 2020 Jan; 39(1):84-92. PubMed ID: 30575604
[TBL] [Abstract][Full Text] [Related]
26. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
Silva EG; Gershenson DM; Malpica A; Deavers M
Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
[TBL] [Abstract][Full Text] [Related]
27. [Diagnosis of ovarian tumors by sonography].
Wu ZY; Zhang GY; Du ZB
Zhonghua Fu Chan Ke Za Zhi; 1994 Feb; 29(2):100-2, 125. PubMed ID: 8033625
[TBL] [Abstract][Full Text] [Related]
28. Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors.
Burks RT; Sherman ME; Kurman RJ
Am J Surg Pathol; 1996 Nov; 20(11):1319-30. PubMed ID: 8898836
[TBL] [Abstract][Full Text] [Related]
29. The power Doppler velocity index, pulsatility index, and resistive index can assist in making a differential diagnosis of primary ovarian carcinoma and Krukenberg tumors: a preliminary study.
Chen CY; Wu YC; Yen MS; Hung JH; Yuan CC; Chao KC
J Ultrasound Med; 2007 Jul; 26(7):921-6; quiz 927-9. PubMed ID: 17592055
[TBL] [Abstract][Full Text] [Related]
30. [Preliminary study on the relationship between tubal intraepithelial carcinoma of the fimbria and pelvic high-grade serous carcinoma].
Liang Y; Chen XD; Lü BJ; Zhou CY; Zhang XF; Shi HY
Zhonghua Fu Chan Ke Za Zhi; 2011 Oct; 46(10):724-8. PubMed ID: 22321343
[TBL] [Abstract][Full Text] [Related]
31. Endometrioid adenocarcinoma of the ovary mimicking serous borderline tumor: report of a series of cases.
Mansor S; McCluggage WG
Int J Gynecol Pathol; 2014 Sep; 33(5):470-6. PubMed ID: 25083962
[TBL] [Abstract][Full Text] [Related]
32. Low-grade serous tumors of ovary.
Bell DA
Int J Gynecol Pathol; 2014 Jul; 33(4):348-56. PubMed ID: 24901394
[TBL] [Abstract][Full Text] [Related]
33. Imaging in gynecological disease (8): ultrasound characteristics of recurrent borderline ovarian tumors.
Franchi D; Boveri S; Fruscio R; Fischerova D; Guerriero S; Moruzzi MC; Colombo N; Timmerman D; Valentin L; Testa AC
Ultrasound Obstet Gynecol; 2013 Apr; 41(4):452-8. PubMed ID: 22858859
[TBL] [Abstract][Full Text] [Related]
34. Low-grade ovarian serous neoplasms (low-grade serous carcinoma and serous borderline tumor) associated with high-grade serous carcinoma or undifferentiated carcinoma: report of a series of cases of an unusual phenomenon.
Boyd C; McCluggage WG
Am J Surg Pathol; 2012 Mar; 36(3):368-75. PubMed ID: 22082603
[TBL] [Abstract][Full Text] [Related]
35. Malignant ascites occurs most often in patients with high-grade serous papillary ovarian cancer at initial diagnosis: a retrospective analysis of 191 women treated at Bayreuth Hospital, 2006-2015.
Krugmann J; Schwarz CL; Melcher B; Sterlacci W; Ozalinskaite A; Lermann J; Agaimy A; Vieth M
Arch Gynecol Obstet; 2019 Feb; 299(2):515-523. PubMed ID: 30415435
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of MTAP immunohistochemistry loss of expression in ovarian serous borderline tumors as a potential marker for prognosis and progression.
Nilforoushan N; Moatamed NA
Ann Diagn Pathol; 2020 Oct; 48():151582. PubMed ID: 32866902
[TBL] [Abstract][Full Text] [Related]
37. Metabolic Markers and Statistical Prediction of Serous Ovarian Cancer Aggressiveness by Ambient Ionization Mass Spectrometry Imaging.
Sans M; Gharpure K; Tibshirani R; Zhang J; Liang L; Liu J; Young JH; Dood RL; Sood AK; Eberlin LS
Cancer Res; 2017 Jun; 77(11):2903-2913. PubMed ID: 28416487
[TBL] [Abstract][Full Text] [Related]
38. Grade 1 peritoneal serous carcinomas: a report of 14 cases and comparison with 7 peritoneal serous psammocarcinomas and 19 peritoneal serous borderline tumors.
Weir MM; Bell DA; Young RH
Am J Surg Pathol; 1998 Jul; 22(7):849-62. PubMed ID: 9669347
[TBL] [Abstract][Full Text] [Related]
39. Characterization of papillary projections in benign versus borderline and malignant ovarian masses on conventional and color Doppler ultrasound.
Hassen K; Ghossain MA; Rousset P; Sciot C; Hugol D; Baddoura R; Vadrot D; Buy JN
AJR Am J Roentgenol; 2011 Jun; 196(6):1444-9. PubMed ID: 21606312
[TBL] [Abstract][Full Text] [Related]
40. Fascin expression in serous tumors of ovary correlates with aggressiveness of malignancy.
Wen YH; Yee H; Goswami S; Shukla PS
Int J Gynecol Pathol; 2009 Mar; 28(2):187-92. PubMed ID: 19188814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]